Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Bioorg Chem ; 90: 103031, 2019 09.
Article de Anglais | MEDLINE | ID: mdl-31238181

RÉSUMÉ

Curcumin is a plant diphenylheptanoid and has been investigated for its antibacterial activity. However, the therapeutic uses of this compound are limited due to its chemical instability. In this work, we evaluated the antimicrobial activity of diphenylheptanoids derived from curcumin against Gram-positive and Gram-negative bacteria, and also against Mycobacterium tuberculosis in terms of MIC (Minimum Inhibitory Concentration) and MBC (Minimum Bactericidal Concentration) values. 3,3'-Dihydroxycurcumin (DHC) displayed activity against Enterococcus faecalis, Staphylococcus aureus and M. tuberculosis, demonstrating MIC values of 78 and 156 µg/mL. In addition, DHC was more stable than curcumin in acetate buffer (pH 5.0) and phosphate buffer (pH 7.4) for 24 h at 37 °C. We proposed that membrane and the cell division protein FtsZ could be the targets for DHC due to that fact that curcumin exhibits this mode of antibacterial action. Fluorescence microscopy of Bacillus subtilis stained with SYTO9 and propidium iodide fluorophores indicated that DHC has the ability to perturb the bacterial membrane. On the other hand, DHC showed a weak inhibition of the GTPase activity of B. subtilis FtsZ. Toxicity assay using human cells indicated that DHC has moderate capacity to reduce viability of liver cells (HepG2 line) and lung cells (MRC-5 and A549 lines) when compared with doxorubicin. Alkaline comet assay indicated that DHC was not able to induce DNA damage in A549 cell line. These results indicated that DHC is promising compound with antibacterial and antitubercular activities.


Sujet(s)
Antituberculeux/pharmacologie , Membrane cellulaire/effets des médicaments et des substances chimiques , Curcumine/analogues et dérivés , Curcumine/pharmacologie , Antituberculeux/synthèse chimique , Antituberculeux/toxicité , Bactéries/effets des médicaments et des substances chimiques , Protéines bactériennes/antagonistes et inhibiteurs , Lignée cellulaire tumorale , Curcumine/toxicité , Protéines du cytosquelette/antagonistes et inhibiteurs , ADN/effets des médicaments et des substances chimiques , Stabilité de médicament , dGTPases/antagonistes et inhibiteurs , Humains , Tests de sensibilité microbienne
2.
Int J Mol Sci ; 19(10)2018 Oct 06.
Article de Anglais | MEDLINE | ID: mdl-30301234

RÉSUMÉ

Xanthomonas citri subsp. citri (Xcc) causes citrus canker, affecting sweet orange-producing areas around the world. The current chemical treatment available for this disease is based on cupric compounds. For this reason, the objective of this study was to design antibacterial agents. In order to do this, we analyzed the anti-Xcc activity of 36 alkyl dihydroxybenzoates and we found 14 active compounds. Among them, three esters with the lowest minimum inhibitory concentration values were selected; compounds 4 (52 µM), 16 (80 µM) and 28 (88 µM). Our study demonstrated that alkyl dihydroxybenzoates cause a delay in the exponential phase. The permeability capacity of alkyl dihydroxybenzoates in a quarter of MIC was compared to nisin (positive control). Compound 28 was the most effective (93.8), compared to compound 16 (41.3) and compound 4 (13.9) by percentage values. Finally, all three compounds showed inhibition of FtsZ GTPase activity, and promoted changes in protofilaments, leading to depolymerization, which prevents bacterial cell division. In conclusion, heptyl dihydroxybenzoates (compounds 4, 16 and 28) are promising anti-Xcc agents which may serve as an alternative for the control of citrus canker.


Sujet(s)
Antibactériens/composition chimique , Antibactériens/pharmacologie , Conception de médicament , Hydroxybenzoates/composition chimique , Hydroxybenzoates/pharmacologie , Xanthomonas/effets des médicaments et des substances chimiques , Antibactériens/synthèse chimique , Antibactériens/isolement et purification , Perméabilité des membranes cellulaires/effets des médicaments et des substances chimiques , dGTPases/antagonistes et inhibiteurs , Hydroxybenzoates/synthèse chimique , Tests de sensibilité microbienne , Structure moléculaire , Maladies des plantes/microbiologie
3.
Biochim Biophys Acta ; 1813(10): 1708-16, 2011 Oct.
Article de Anglais | MEDLINE | ID: mdl-21782856

RÉSUMÉ

Parcs/Gpn3 is a putative GTPase that is conserved in eukaryotic cells from yeast to humans, suggesting that it plays a fundamental, but still unknown, cellular function. Suppression of Parcs/Gpn3 expression by RNAi completely blocked cell proliferation in MCF-12A cells and other mammary epithelial cell lines. Unexpectedly, Parcs/Gpn3 knockdown had a more modest effect in the proliferation of the tumorigenic MDA-MB-231 and SK-BR3 cells. RNA polymerase II (RNAP II) co-immunoprecipitated with Parcs/Gpn3. Parcs/Gpn3 depletion caused a reduction in overall RNA synthesis in MCF-12A cells but not in MDA-MB-231 cells, demonstrating a role for Parcs/Gpn3 in transcription, and pointing to a defect in RNA synthesis by RNAP II as the possible cause of halted proliferation. The absence of Parcs/Gpn3 in MCF-12A cells caused a dramatic change in the sub-cellular localization of Rpb1, the largest subunit of RNAP II. As expected, Rpb1 was present only in the nucleus of MCF-12A control cells, whereas in Parcs/Gpn3-depleted MCF-12A cells, Rpb1 was detected exclusively in the cytoplasm. This effect was specific, as histones remained nuclear independently of Parcs/Gpn3. Rpb1 protein levels were markedly increased in Parcs/Gpn3-depleted MCF-12A cells. Interestingly, Rpb1 distribution was only marginally affected after knocking-down Parcs/Gpn3 in MDA-MB-231 cells. In conclusion, we report here, for the first time, that Parcs/Gpn3 plays a critical role in the nuclear accumulation of RNAP II, and we propose that this function explains the relative importance of Parcs/Gpn3 in cell proliferation. Intriguingly, at least some tumorigenic mammary cells have evolved mechanisms that allow them to proliferate in a Parcs/Gpn3-independent manner.


Sujet(s)
Noyau de la cellule/métabolisme , dGTPases/physiologie , RNA polymerase II/métabolisme , Région mammaire/métabolisme , Noyau de la cellule/génétique , Prolifération cellulaire/effets des médicaments et des substances chimiques , Cellules cultivées , Cellules épithéliales/métabolisme , Femelle , dGTPases/antagonistes et inhibiteurs , dGTPases/génétique , dGTPases/métabolisme , Humains , Immunoprécipitation , Liaison aux protéines , Transport des protéines/génétique , Interférence par ARN/physiologie , Petit ARN interférent/pharmacologie , Activation de la transcription/effets des médicaments et des substances chimiques , Activation de la transcription/génétique
4.
Arch Biochem Biophys ; 465(2): 315-9, 2007 Sep 15.
Article de Anglais | MEDLINE | ID: mdl-17678870

RÉSUMÉ

FtsZ (Filamentous temperature sensitivity Z) cell division protein from Escherichia coli binds the fluorescence probe DAPI. Bundling of FtsZ was facilitated in the presence of DAPI, and the polymers in solution remained polymerized longer time than the protofilaments formed in the absence of DAPI. DAPI decreased both the maximal velocity of the GTPase activity and the Michaelis-Menten constant for GTP, indicating that behaves like an uncompetitive inhibitor of the GTPase activity favoring the GTP form of FtsZ in the polymers. The results presented in this work support a cooperative polymerization mechanism in which the binding of DAPI favors protofilament lateral interactions and the stability of the resulting polymers.


Sujet(s)
Protéines Escherichia coli/composition chimique , Escherichia coli/métabolisme , dGTPases/antagonistes et inhibiteurs , Indoles/composition chimique , Dimérisation , Activation enzymatique , Complexes multiprotéiques/composition chimique , Liaison aux protéines
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE